Cannabis Global, Inc. (CBGL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cannabis Global, Inc. (CBGL) trades at $0.00 with AI Score 46/100 (Grade C). Cannabis Global, Inc. focuses on developing and commercializing technologies for delivering hemp extracts and cannabinoids. Market cap: $56,821, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for CBGL: CBGL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CBGL against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CBGL: the 1 perspectives are evenly split.
How is this calculated? →Cannabis Global, Inc. (CBGL) Healthcare & Pipeline Overview
Cannabis Global, Inc. operates in the specialty drug manufacturing sector, focusing on engineered technologies for cannabinoid delivery. The company provides cannabis flower, pre-rolls, edibles, and storage solutions, targeting retailers and distributors in the regulated hemp and cannabis industries, while facing competition in a rapidly evolving market.
What Is the Investment Thesis for CBGL?
Cannabis Global, Inc. presents a speculative investment opportunity within the cannabis industry, characterized by high growth potential and significant regulatory uncertainty. With a market capitalization of 57K and a negative P/E ratio of -2.79, the company's financial performance reflects its early stage and ongoing investments. The company's focus on engineered technologies for cannabinoid delivery and its Comply Bag solution offer potential differentiation in a competitive market. However, the OTC market listing and limited financial disclosure introduce substantial risk. Key growth catalysts include expansion of product offerings and successful penetration of new geographic markets. Investors should carefully consider the company's limited operating history, reliance on the evolving regulatory landscape, and the competitive pressures within the cannabis industry.
Based on FMP financials and quantitative analysis
CBGL Key Highlights
- Focus on engineered technologies for cannabinoid delivery, potentially offering differentiated products.
- Offers Comply Bag, a solution for cannabis storage, transport, and tracking, addressing a compliance need.
- Provides managerial services in the regulated hemp and cannabis industries, diversifying revenue streams.
- Market capitalization of 57K indicates a micro-cap company with high growth potential and associated risks.
- Negative P/E ratio of -2.79 reflects current unprofitability and ongoing investments in growth initiatives.
Who Are CBGL's Competitors?
CBGL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CBGL's Key Strengths?
- Focus on engineered technologies for cannabinoid delivery.
- Comply Bag solution addresses a specific compliance need.
- Provides managerial services in the regulated hemp and cannabis industries.
- Established presence in the California cannabis market.
What Are CBGL's Weaknesses?
- Limited financial resources and profitability.
- Small number of employees.
- Dependence on the evolving regulatory landscape.
- OTC market listing indicates higher risk and lower liquidity.
What Could Drive CBGL Stock Higher?
- Potential legalization of cannabis in new states and countries could expand market opportunities.
- Development and launch of new cannabinoid-based products and formulations.
- Expansion of strategic partnerships and acquisitions to enhance capabilities and market reach.
- Increased demand for regulatory compliance solutions in the cannabis industry.
- Growing consumer acceptance of cannabis for medical and recreational use.
What Are the Key Risks for CBGL?
- Financial-distress signal — its Altman Z-Score of -49.67 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Changes in cannabis regulations could negatively impact the company's operations and profitability.
- Intense competition from larger and more established cannabis companies.
- Limited financial resources and profitability constrain growth opportunities.
- Dependence on the evolving regulatory landscape creates uncertainty.
- OTC market listing indicates higher risk and lower liquidity.
What Are the Growth Opportunities for CBGL?
- Expansion of Product Offerings: Cannabis Global can expand its product line to include new cannabinoid-based products, formulations, and delivery methods. The market for novel cannabis products is growing rapidly, driven by consumer demand for innovative and effective solutions. Successful product development and commercialization could significantly increase revenue and market share. Timeline: Ongoing.
- Geographic Market Expansion: Cannabis Global can expand its geographic reach by entering new states and countries where cannabis is legal. The global cannabis market is expanding rapidly, offering significant opportunities for growth. Successful expansion into new markets could significantly increase revenue and brand recognition. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Cannabis Global can pursue strategic partnerships and acquisitions to expand its capabilities, access new markets, and enhance its product offerings. Strategic alliances can provide access to new technologies, distribution channels, and customer segments. Timeline: Ongoing.
- Development of Proprietary Technologies: Cannabis Global can invest in the development of proprietary technologies for cannabinoid extraction, formulation, and delivery. Proprietary technologies can provide a competitive advantage and create barriers to entry for competitors. Timeline: Ongoing.
- Increased Focus on Regulatory Compliance: Cannabis Global can capitalize on the increasing demand for regulatory compliance solutions in the cannabis industry. The company's Comply Bag solution and managerial services address a critical need for compliance with complex regulations. Timeline: Ongoing.
What Opportunities Does CBGL Have?
- Expansion into new geographic markets.
- Development of new cannabinoid-based products and formulations.
- Strategic partnerships and acquisitions.
- Increased demand for regulatory compliance solutions.
What Threats Does CBGL Face?
- Intense competition from larger cannabis companies.
- Changing regulatory landscape and potential for increased regulation.
- Fluctuations in cannabis prices and demand.
- Potential for product recalls and liability claims.
What Are CBGL's Competitive Advantages?
- Proprietary engineered technologies for cannabinoid delivery.
- Comply Bag solution addresses a specific need for regulatory compliance in cannabis storage and transport.
- Expertise in the regulated hemp and cannabis industries provides a competitive advantage in managerial services.
What Does CBGL Do?
Cannabis Global, Inc., originally incorporated in 2005 as MCTC Holdings, underwent a transformation in December 2019, rebranding to reflect its focus on the cannabis industry. Headquartered in Los Angeles, California, the company specializes in creating and commercializing engineered technologies designed to deliver hemp extracts and cannabinoids to the human body. Cannabis Global's product portfolio includes a range of cannabis flower products, such as packaged flower, pre-rolls, and edible products, which are distributed to cannabis retailers and distributors. Additionally, the company offers Comply Bag, a solution tailored for cannabis storage, transport, and tracking, addressing a critical need for compliance within the regulated industry. Beyond its product offerings, Cannabis Global provides managerial services, leveraging its expertise in the regulated hemp and cannabis sectors to assist other businesses. This multifaceted approach positions Cannabis Global as a participant in both the product and service segments of the cannabis market, aiming to capitalize on the increasing demand for innovative cannabis solutions and regulatory compliance support.
What Products and Services Does CBGL Offer?
- Creates and commercializes engineered technologies for delivering hemp extracts and cannabinoids.
- Offers packaged cannabis flower products to retailers and distributors.
- Provides pre-rolled cannabis products.
- Manufactures and distributes cannabis edible products.
- Offers Comply Bag, a solution for cannabis storage, transport, and tracking.
- Provides managerial services in the regulated hemp and cannabis industries.
How Does CBGL Make Money?
- Sells cannabis flower, pre-rolls, and edible products to cannabis retailers and distributors.
- Generates revenue from the sale of Comply Bag, a cannabis storage and tracking solution.
- Provides managerial services to businesses in the regulated hemp and cannabis industries.
What Industry Does CBGL Operate In?
Cannabis Global, Inc. operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization, growing consumer demand, and intense competition. The market is driven by trends such as the increasing acceptance of cannabis for medical and recreational use, the development of innovative cannabis-based products, and the expansion of distribution channels. Cannabis Global competes with other companies in the cannabis product and service segments, including ATTBF (Aurora Cannabis Inc.), BIOIF (BioHarvest Sciences Inc.), HENC (Hemp, Inc.), INLB (InnoLabs, Inc.), and INSD (Inspiradigm, Inc.). The company's success depends on its ability to differentiate its products, navigate the complex regulatory landscape, and effectively compete for market share.
Who Are CBGL's Key Customers?
- Cannabis retailers
- Cannabis distributors
- Businesses in the regulated hemp and cannabis industries seeking managerial services.
Company Profile
Cannabis Global, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Edward Manolos. CBGL has traded publicly since 2008.
Cannabis Global, Inc. (CBGL) Valuation Context
Valued at 57K, CBGL is classified as a micro-cap stock. Relative to its peer group, CBGL's quantitative score of 46/100 is below the peer average of 66/100.
ROE 4%Key Financial Metrics
Return on equity for Cannabis Global, Inc. stands at 4.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -21.8%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -29.4%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Cannabis Global, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -49.67 places it in the distress zone, a signal of elevated financial risk.
CBGL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence in the company’s future, suggesting that executives believe in the growth potential of Cannabis Global.
- Community sentiment has shifted positively with increasing discussions around the cannabis industry’s expansion, particularly in emerging markets.
- New product launches have generated excitement, with social media buzz highlighting innovative offerings that could attract new customers.
- The overall trend towards cannabis legalization is gaining momentum, positioning Cannabis Global favorably within a rapidly evolving market.
Bear Case
- Concerns surrounding regulatory challenges persist, as potential changes in legislation could impact the operational landscape for Cannabis Global.
- Recent negative sentiment in cannabis stocks due to broader market volatility has led to skepticism among investors.
- Increased competition in the cannabis sector raises questions about Cannabis Global's ability to maintain market share amid aggressive rivals.
- Community discussions indicate apprehension about the company’s financial health, with calls for more transparency in reporting and future guidance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CBGL Latest News
No recent news available for CBGL.
CBGL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBGL.
Price Targets
Wall Street price target analysis for CBGL.
CBGL MoonshotScore
What does this score mean?
The MoonshotScore rates CBGL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Edward Manolos
CEO
Edward Manolos serves as the CEO of Cannabis Global, Inc. His background includes experience in managing and developing businesses, with a focus on emerging industries. He has been involved in strategic planning, business development, and operational management. His leadership is focused on driving innovation and growth within the cannabis sector.
Track Record: Under Edward Manolos' leadership, Cannabis Global, Inc. has focused on developing and commercializing engineered technologies for cannabinoid delivery. Key milestones include the launch of the Comply Bag solution and the expansion of the company's product offerings. He is responsible for navigating the company through the evolving regulatory landscape and fostering strategic partnerships.
CBGL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannabis Global, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors compared to companies listed on major exchanges like the NYSE or NASDAQ. These companies may also face greater scrutiny regarding their operations and financial stability.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in Cannabis Global, Inc.
- Low trading volume and wide bid-ask spread can make it difficult to buy or sell shares.
- OTC Other tier status indicates a higher level of risk compared to stocks listed on major exchanges.
- Dependence on the evolving regulatory landscape of the cannabis industry.
- Intense competition from larger and more established cannabis companies.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's competitive position and market share.
- Evaluate the company's regulatory compliance and risk management practices.
- Analyze the company's cash flow and financial stability.
- Check for any legal or regulatory issues involving the company.
- Consult with a qualified financial advisor before investing.
- Focus on engineered technologies for cannabinoid delivery suggests innovation.
- Comply Bag solution addresses a specific need for regulatory compliance.
- Provides managerial services in the regulated hemp and cannabis industries, indicating expertise.
- Operating history since 2005 provides some level of established presence.
- Headquartered in Los Angeles, California, a major cannabis market.
Common Questions About CBGL (Healthcare)
What does Cannabis Global, Inc. do?
Cannabis Global, Inc. focuses on the creation and commercialization of engineered technologies to deliver hemp extracts and cannabinoids. The company offers a range of cannabis products, including packaged flower, pre-rolls, and edibles, which are distributed to cannabis retailers and distributors. Additionally, Cannabis Global provides Comply Bag, a solution for cannabis storage, transport, and tracking, addressing a critical need for compliance within the regulated industry. The company also offers managerial services to businesses operating in the regulated hemp and cannabis sectors.
What do analysts say about CBGL stock?
As of 2026-03-17, there is no readily available analyst coverage for Cannabis Global, Inc. (CBGL) due to its OTC listing and small market capitalization. The company's valuation metrics, such as its negative P/E ratio, reflect its current unprofitability and ongoing investments in growth initiatives. Investors should conduct their own thorough analysis of the company's financials, operations, and competitive landscape before making any investment decisions. The absence of analyst coverage highlights the speculative nature of this investment.
What are the main risks for CBGL?
Cannabis Global, Inc. faces several key risks, including its limited financial resources, dependence on the evolving regulatory landscape of the cannabis industry, and intense competition from larger and more established companies. The company's OTC market listing indicates higher risk and lower liquidity compared to stocks listed on major exchanges. Changes in cannabis regulations could negatively impact the company's operations and profitability. Additionally, the potential for product recalls and liability claims poses a significant threat.
What are the key factors to evaluate for CBGL?
Cannabis Global, Inc. (CBGL) holds an AI score of 46/100 (low). Not financial advice.
How frequently does CBGL data refresh on this page?
CBGL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CBGL's recent stock price performance?
Cannabis Global, Inc. (CBGL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on engineered technologies for cannabinoid delivery. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CBGL overvalued or undervalued right now?
Valuing Cannabis Global, Inc. (CBGL) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CBGL?
Before investing in Cannabis Global, Inc. (CBGL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available due to OTC listing.
- Analyst coverage is non-existent.